Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06880653 · ClinicalTrials.gov registry record · NA

Dose Response of Exercise for Arthritis Management

A NA study of Osteoarthritis and Arthritis, sponsored by University of South Carolina.

Recruiting
Registry status
NA
Development phase
285
Enrollment target
1
Study location

NCT06880653 is a NA study of Osteoarthritis and Arthritis that is actively recruiting participants, run by University of South Carolina. The registered enrollment target is 285 participants, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06880653, a NA study of Osteoarthritis and Arthritis, is actively recruiting participants, sponsored by University of South Carolina.

RECRUITING
Registry status
NA
Development phase
285 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to see examine the effects of 3 different levels of physical activity (45 minutes/week, 90 minutes/week, or 150 minutes/week) on arthritis symptoms.

Interventions

  • BEHAVIORAL DREAM Adaptive Intervention

Study Locations (1)

South Carolina

  • University of South Carolina - Columbia

Trial Details

FieldValue
Enrollment Target 285 participants
Start Date 2025-03-28
Est. Completion 2029-04-30
Phase NA

Sponsor

University of South Carolina

157 total trials

What the Registry Record Tells You About NCT06880653

The ClinicalTrials.gov registry entry for NCT06880653 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (65% lower). The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which DREAM Adaptive Intervention is the first listed.

NCT06880653 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT06880653 about?

NCT06880653 is a clinical study titled "Dose Response of Exercise for Arthritis Management". The purpose of the study is to see examine the effects of 3 different levels of physical activity (45 minutes/week, 90 minutes/week, or 150 minutes/week) on arthritis symptoms.

What is the current status of trial NCT06880653?

This trial is currently recruiting. It is a NA study. The enrollment target is 285 participants. The study started on 2025-03-28. Estimated completion is 2029-04-30.

What conditions does trial NCT06880653 study?

This clinical trial studies the following conditions: Osteoarthritis, Arthritis, Gout, Lupus Erythematosus, Systemic, Rheumatoid Arthritis (RA).

What interventions are being tested in trial NCT06880653?

The interventions under investigation include: DREAM Adaptive Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06880653?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06880653 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.